Fruitful adrenergic α(2C)-agonism/α(2A)-antagonism combination to prevent and contrast morphine tolerance and dependence
- PMID: 20925410
- DOI: 10.1021/jm100977d
Fruitful adrenergic α(2C)-agonism/α(2A)-antagonism combination to prevent and contrast morphine tolerance and dependence
Abstract
The functional in vitro study of the enantiomers of imidazolines 4-7 highlighted the role played by the nature of the ortho phenyl substituent in determining the preferred α(2C)-AR configuration. Indeed, the (S) enantiomers of 4-6 or (R) enantiomer of 7 behave as eutomers and activate this subtype as full agonists; the corresponding distomers are partial agonists. Because in clinical pain management with opioids α(2C)-AR agonists, devoid of the α(2A)-AR-mediated side effects, may represent an improvement over current therapies with clonidine like drugs, 4 and its enantiomers, showing α(2C)-agonism/α(2A)-antagonism, have been studied in vivo. The data suggest that partial α(2C)-activation is compatible with effective enhancement of morphine analgesia and reduction both of morphine tolerance acquisition and morphine dependence acquisition and expression. On the contrary, full α(2C)-activation appears advantageous in reducing morphine tolerance expression. Interestingly, the biological profile displayed by 4 (allyphenyline) and its eutomer (S)-(+)-4 has been found to be very unusual.
Similar articles
-
Might the observed α(2A)-adrenoreceptor agonism or antagonism of allyphenyline analogues be ascribed to different molecular conformations?Bioorg Med Chem. 2012 Mar 15;20(6):2082-90. doi: 10.1016/j.bmc.2012.01.035. Epub 2012 Jan 31. Bioorg Med Chem. 2012. PMID: 22341244
-
Might adrenergic alpha2C-agonists/alpha2A-antagonists become novel therapeutic tools for pain treatment with morphine?J Med Chem. 2009 Nov 26;52(22):7319-22. doi: 10.1021/jm901262f. J Med Chem. 2009. PMID: 19886609
-
Favourable involvement of α2A-adrenoreceptor antagonism in the I₂-imidazoline binding sites-mediated morphine analgesia enhancement.Bioorg Med Chem. 2012 Apr 1;20(7):2259-65. doi: 10.1016/j.bmc.2012.02.016. Epub 2012 Feb 13. Bioorg Med Chem. 2012. PMID: 22370341
-
Alpha2-adrenergic receptor agonists as analgesics.Curr Top Med Chem. 2001 Aug;1(3):193-7. doi: 10.2174/1568026013395182. Curr Top Med Chem. 2001. PMID: 11895135 Review.
-
Alpha-2 agonists in acute pain management.Expert Opin Pharmacother. 2010 Dec;11(17):2849-68. doi: 10.1517/14656566.2010.511613. Epub 2010 Aug 13. Expert Opin Pharmacother. 2010. PMID: 20707597 Review.
Cited by
-
Applications of Transition Metal-Catalyzed ortho-Fluorine-Directed C-H Functionalization of (Poly)fluoroarenes in Organic Synthesis.Chem Rev. 2024 Apr 24;124(8):4822-4862. doi: 10.1021/acs.chemrev.3c00793. Epub 2024 Apr 2. Chem Rev. 2024. PMID: 38564710 Free PMC article. Review.
-
Biased, Bitopic, Opioid-Adrenergic Tethered Compounds May Improve Specificity, Lower Dosage and Enhance Agonist or Antagonist Function with Reduced Risk of Tolerance and Addiction.Pharmaceuticals (Basel). 2022 Feb 10;15(2):214. doi: 10.3390/ph15020214. Pharmaceuticals (Basel). 2022. PMID: 35215326 Free PMC article. Review.
-
Role of the NMDA Receptor in the Antitumor Activity of Chiral 1,4-Dioxane Ligands in MCF-7 and SKBR3 Breast Cancer Cells.ACS Med Chem Lett. 2019 Jan 28;10(4):511-516. doi: 10.1021/acsmedchemlett.8b00536. eCollection 2019 Apr 11. ACS Med Chem Lett. 2019. PMID: 30996788 Free PMC article.
-
Combined Interactions with I1-, I2-Imidazoline Binding Sites and α2-Adrenoceptors To Manage Opioid Addiction.ACS Med Chem Lett. 2016 Sep 8;7(10):956-961. doi: 10.1021/acsmedchemlett.6b00290. eCollection 2016 Oct 13. ACS Med Chem Lett. 2016. PMID: 27774136 Free PMC article.
-
A Novel Class of Dopamine D4 Receptor Ligands Bearing an Imidazoline Nucleus.ChemMedChem. 2016 Aug 19;11(16):1819-28. doi: 10.1002/cmdc.201600022. Epub 2016 Mar 15. ChemMedChem. 2016. PMID: 26990230 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Chemical Information
Research Materials